ReveNEWS: The Revenue Management Community

Welcome!

Submitted by Nate Taninecz on Tuesday, January 7, 2014 - 12:00am

On Friday, January 27, 2012, the Centers for Medicare & Medicaid Services (CMS) published a Proposed Rule in the Federal Register (RIN# 0938-AQ41) to implement the Medicaid Drug Rebate Program (MDRP) provisions of the Patient Protection and Affordable Care Act (ACA). While the scope of the ruling is wide-ranging and provides manufacturers with a greater understanding of CMS’ position on critical concerns, it also does not answer many questions and will, in all likelihood, have a significant impact on manufacturers’ rebate liabilities and the cost of compliance. It is important to note...

Submitted by Lewis Farrell on Monday, November 25, 2013 - 4:36pm

The 12th Annual Pharmaceutical Industry Audit reports that the US Pharmaceutical industry has had a very tough year. The challenges came from a number of different areas: post-recession strains on public budgets and private-sector employment as well as the steepness of the patent cliff from 2010-2012. The Editor in Chief of Pharmaceutical Executive stated that there was one signal message from the...

Submitted by Kristin Lee Dunning on Monday, November 11, 2013 - 12:16pm

We are proud to announce that Model N has been named a top job creator by the Inc. Hire Power Awards, recognizing the businesses that have generated the most jobs in the past three years! Model N ranked 13 in the software industry and was named to the top 20 job creators list in California, having generated 93 jobs from January 1...

Submitted by Kin Cheung on Wednesday, October 9, 2013 - 11:52am

For manufacturers that rely heavily on direct business, a strategic shift to focus more on distribution sales could prove beneficial. I’ve recently noticed manufacturers focusing more on building their channel or, at least, better leveraging their channel. For example, ST Microelectronics...

Submitted by Scott Medberry on Friday, September 13, 2013 - 2:40pm

September is a time for fall colors, the start of football, and for preparation of the winter to come. For drug manufacturers selling to the US Government, it is also a time to gather in Chicago to discuss the ever-changing rules, regulations, guidance and rumors at the annual Medicaid Drug Rebate Program (MDRP) trade conference. The conference this year had over 600 participants discussing nearly every drug...

Submitted by Arnaud Grunwald on Tuesday, September 10, 2013 - 3:24pm

I regularly speak with strategists at global pharma companies and, lately, the close relationship between global market access and global pricing has often come up. The success of a new drug depends on positive health outcomes, of course, but also on positioning, competitive pricing and many other components that bring about effective reimbursement from increasingly cost-conscious payers, be they public or private. We all know the heydays of the 1990s and early 2000s when most drugs would be reimbursed by payers without problem are long gone. As a result, Market Access teams continue to...